Glen Eagle Advisors’s Labcorp LH Stock Holding History

Glen Eagle Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.85K	Hold	32	–	–	﹤0.01%	721
2026 Q1	$8.41K	Buy	32 +1	+3%	+$271	﹤0.01%	693
2025 Q4	$7.89K	Hold	31	–	–	﹤0.01%	724
2025 Q3	$9.01K	Buy	31 +11	+55%	+$2.95K	﹤0.01%	710
2025 Q2	$5.33K	Hold	20	–	–	﹤0.01%	723
2025 Q1	$4.72K	Hold	20	–	–	﹤0.01%	733
2024 Q4	$4.63K	Hold	20	–	–	﹤0.01%	757
2024 Q3	$4.5K	Buy	+20	New	+$4.4K	﹤0.01%	774
2023 Q1	–	Sell	-3	Closed	-$706	–	1163
2022 Q4	$706	Buy	+3	New	+$586	﹤0.01%	1051
2021 Q3	–	Sell	-22	Closed	-$5.24K	–	1081
2021 Q2	$5.24K	Hold	22	–	–	﹤0.01%	807
2021 Q1	$4.85K	Hold	22	–	–	﹤0.01%	776
2020 Q4	$3.87K	Hold	22	–	–	﹤0.01%	774
2020 Q3	$3.58K	Hold	22	–	–	﹤0.01%	734
2020 Q2	$3.16K	Hold	22	–	–	﹤0.01%	723
2020 Q1	$2.4K	Hold	22	–	–	﹤0.01%	698
2019 Q4	$3.21K	Hold	22	–	–	﹤0.01%	751
2019 Q3	$3.19K	Buy	+22	New	+$3.21K	﹤0.01%	680

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Glen Eagle Advisors's LH Position: Q2 2026 in Review

Glen Eagle Advisors held its Labcorp (LH) position steady in Q2 2026 at 32 shares worth $8.85K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Glen Eagle Advisors first reported a position in LH in Q3 2019 and has held it in 17 quarters since. The position peaked at $9.01K in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Glen Eagle Advisors held 32 shares of Labcorp worth $8.85K as of Q2 2026.
Glen Eagle Advisors left its Labcorp share count unchanged in Q2 2026.
Labcorp made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #721 holding.
Glen Eagle Advisors first reported a position in Labcorp in Q3 2019 and has held it in 17 quarters since.
Glen Eagle Advisors's Labcorp position peaked at $9.01K in Q3 2025.
1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.